Global Diabetes Care Devices Market Size & Growth (2019 - 2024)
As per our report, the size of the Global Diabetes Care Devices Market has been estimated at USD 20.4 Billion in 2019 and is projected to reach USD 27.0 Billion by 2024, at a CAGR of 5.79% during the forecast period from 2019 to 2024. Diabetes is a group of metabolic disorders, chronic condition which is associated with an abnormally high level of sugar (glucose) in the blood. The diabetes patient pool is expected to reach 380 million by 2025 because of the drastic rise in population, sedentary lifestyle, unhealthy dietary patterns, etc.
The market-driven by factors like an increasing pool of patients suffering from diabetes, more investments in R&D resulting in technological innovations, diabetes diagnosis and treatments with minimally to non-invasive techniques.
Furthermore, by increasing awareness, improving diagnosis and treatment rates, a growing need among people for safer, faster and effective methods will lead to increased adoption rates for care devices.
However, the market is restricted by the high costs associated with diagnosis and treatment. Moreover, reimbursement issues and patent expiry are also an issue. The diabetes care devices offer a solution to diabetes patients to manage glucose in the blood.
Recent Developments:
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Type, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Roche Diagnostics, Johnson & Johnson, LifeScan, Inc. and Animas Inc., Becton-Dickinson, Novo Nordisk, Bayer AG, Abbott Laboratories, Ypsomed AG, Medtronic plc, Insulet Inc., Terumo Corporation, Dexcom, Inc. (U.S.) and Tandem Diabetes Care, Inc. |
This research report on Global Diabetes Care Devices Market segmented & sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.
Diabetes Care Devices Market - By Type:
Based on type, the market is led by glucose monitoring devices. Increasing the prevalence of effective diabetes management procedures in hospitals and clinics is lavishing the growth rate of the market. Growing awareness in monitoring glucose levels regularly is also one of the factors dominating the shares of the market. Shifting trends towards self-medication and rise in the demand for point of care testing devices are accelerating the growth rate of the diabetes care devices market. Initiative steps by the government by increasing campaign programs especially in rural areas is promoting the growth of the market to the extent. The insulin delivery systems segment is expected to have the highest CAGR in the coming years with the improving diagnosis procedures with different systems and also people demand effective and faster methods are enhancing the demand of the market. Minimally invasive treatment procedures are also a part of treating diabetes which is also fueling the growth of the market.
Regional Analysis:
Among these, North America held the largest share in the global diabetes care products market. Europe and Asia-Pacific follow North America’s way.
Especially the Asia-Pacific region provides significant opportunities for the diabetes care in which China (1.3 billion) and India (1.2 billion) being the most populous countries in this region, contribute to the demand for diabetes care devices.
According to the International Diabetes Federation, China had the largest number of diabetic patients with around 96.2 million and India had around 66.8 million diabetic patients.
As of 2018, approximately 45% of the global diabetic population is from China and India. So many global diabetes care devices companies show interest to invest in these countries.
Few of the major companies dominating the Global Diabetes Care Devices Market profiled in this report are:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Global Diabetes Care Devices Market, by Type
5.1.1 Glucose Monitoring Devices
5.1.1.1 Self Blood Glucose Monitoring Devices
5.1.1.1.1 Glucose Meters
5.1.1.1.2 Test strips
5.1.1.1.3 Lancets
5.1.1.1.4 Hemoglobin A1C testing Kits
5.1.1.2 Continous Glucose Monitoring Devices
5.1.2 Insulin Delivery Systems
5.1.2.1 Insulin Syringes
5.1.2.2 Insulin Pens
5.1.2.3 Insulin Pumps
5.1.2.4 Jet Injectors
5.1.3 Control Solutions
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.2.7 Switzerland
6.2.8 Russia
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 F. Hoffmann-La Roche Ltd
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Medtronic Inc.
8.3 Johnson & Johnson
8.4 Abbott Laboratories
8.5 Becton, Dickinson and Company
8.6 Ascensia Diabetes care
8.7 Novo Nordisk A/S
8.8 Dexcom, Inc.
8.9 Insulet Corporation
8.10 Terumo Corporation
8.11 Tandem Diabetes Care, Inc
8.12 Ypsomed AG
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
Related Reports
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
